Zimbabwe has rejected a major American healthcare agreement valued at $367m (272 million pounds) over five years because of Washington's request for confidential data.
The decision was revealed following a internal memorandum from December was leaked, revealing that Head of State Emmerson Mnangagwa believed the deal was "skewed".
An official spokesperson later clarified that the United States was requesting biological samples for scientific study and commercial purposes while was not willing to share the resulting advantages from future vaccines.
"We will now turn to the challenging and unfortunate task of scaling back our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the United States had furnished over $1.9bn as health assistance to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has called for more dialogue to find a deal agreeable to all parties so the country's critical HIV treatment initiative can continue.
Broader Implications
This rejection comes after a similar situation in neighbouring Kenya, where a court suspended a related health funding agreement following legal challenges were filed about the security of citizens' health data.
After returning to office recently, US President Donald Trump has drastically cut overseas assistance and closed the key foreign aid agency.
The agency had administered assistance for the US government, but Trump claimed its spending was "inefficient" and his administration was seeking government-to-government agreements to boost transparency and responsibility.
As per reports, Sixteen nations in Africa have so far agreed to similar agreements, representing over $18.3bn in committed funds.
Details of the Declined Deal
The money for Zimbabwe would have funded "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this partnership might have yielded extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million currently on antiretroviral therapy through US-supported programmes," the Ambassador added.
However, government spokesperson Nick Mangwana said the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to share its biological resources and data indefinitely, with no equivalent assurance of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that shared data," Mangwana explained.
"Put simply, our country would provide the raw materials for medical research without any certainty that the final treatments would be accessible to our people if a new health crisis emerge."
National Interest and Global Health
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were upending frameworks previously established via the global organization.
The spokesperson cited its Pandemic Benefit-Sharing system designed to deal with potential global health emergencies.
"This system is intended to ensure that when a country provides its data, the resulting advantages – such as vaccines and treatments – are distributed fairly, not monopolised solely by those with the funds to develop them."
The government's concerns regarding the US deal "must not be interpreted as opposition to America," he added.
"We welcome continued dialogue with our American counterparts on how future collaboration might be arranged in a way that honours the independence and interests of both nations."
Health Experts Response
A leading public health body stated it recognised the official position, but recommended that talks must proceed since much of the country's HIV programmes depended on international support.
"Where specific concerns exist, including those relating to information security or implementation frameworks, these can frequently be resolved through detailed discussion and negotiated safeguards," the group said.
The situation emphasises the complex tensions between accepting vital foreign assistance and safeguarding a country's data in an increasingly data-driven world.